Related Experiment Videos
Part XIII. Systemic antifungal therapy
Kristin H Busse1, Chris A Gentry, Michael S Bronze
1Infectious Diseases Secton, Oklahoma City, OK 73190, USA.
Abstract:
Until the last decade of the 20th century, intravenous amphotericin B deoxycholate was the only agent available to treat the relatively rare occurrence of serious systemic fungal infections. In response to an explosion in the incidence of systemic fungal infections, within a 15 year period, four new classes of antifungal agents were introduced: the triazoles, liposomal amphotericin B preparations, an allylamine, and echinocandins (Table 1). So an updated review of antifungal therapy is in order.
Insights
Serious systemic fungal infections were once rare, treated only by amphotericin B deoxycholate. A rise in infections led to new antifungal drugs, necessitating an updated review of treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Systemic fungal infections were historically rare and primarily treated with intravenous amphotericin B deoxycholate.
- The late 20th century saw a significant increase in the incidence of serious systemic fungal infections.
Purpose of the Study:
- To provide an updated review of antifungal therapy in light of new drug classes.
- To address the evolving landscape of treating systemic fungal infections.
Main Methods:
- Literature review of antifungal agents introduced in the last 15 years.
- Analysis of the emergence of new antifungal drug classes.
Main Results:
- Four new classes of antifungal agents were introduced within a 15-year period.
- These new classes include triazoles, liposomal amphotericin B preparations, allylamines, and echinocandins.
Conclusions:
- The development of new antifungal agents has expanded treatment options.
- An updated review is crucial due to the increased incidence and availability of diverse antifungal therapies.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Endocarditis III: Medical Management
Candidiasis
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...